基本信息
浏览量:36
职业迁徙
个人简介
Dr. Qing Yi is a trained medical immunologist with over 25 years of experience as a well-funded and published researcher. He is one of the leading investigators in the fields of tumor immunology and immunotherapy in multiple myeloma and other cancers.
Since arriving in the US in 1998, Dr. Yi has been awarded, as the PI, 9 R01s from NCI, 1 project and 1 core grant in the MDACC Myeloma SPORE (P50), 4 R01-type translational grants from the LLS, 4 Senior Researcher Awards from the MMRF, 2 K99/R00 grants (as the mentor), and numerous intramural and industry grants. Dr. Yi and colleagues have published more than 160 peer-reviewed research articles, with 45 being in top-tier journals with an impact factor of greater than 10.
Since arriving in the US in 1998, Dr. Yi has been awarded, as the PI, 9 R01s from NCI, 1 project and 1 core grant in the MDACC Myeloma SPORE (P50), 4 R01-type translational grants from the LLS, 4 Senior Researcher Awards from the MMRF, 2 K99/R00 grants (as the mentor), and numerous intramural and industry grants. Dr. Yi and colleagues have published more than 160 peer-reviewed research articles, with 45 being in top-tier journals with an impact factor of greater than 10.
研究兴趣
论文共 340 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nature Communicationsno. 1 (2024): 615-615
FRONTIERS IN IMMUNOLOGY (2024): 1322746-1322746
Cancer Researchno. 6_Supplement (2024): 3606-3606
Cancer Researchno. 6_Supplement (2024): 2821-2821
NATURE COMMUNICATIONSno. 1 (2024)
Jianfei Qian,Qiang Wang,Liuling Xiao,Wei Xiong,Miao Xian,Pan Su,Maojie Yang, Chuanchao Zhang, Yabo Li, Ling Zhong,Siddhartha Ganguly,Youli Zu,
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 1 (2024)
Cancer Researchno. 6_Supplement (2024): 364-364
BLOOD (2023): 6569
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn